KEY TAKEAWAYS Novartis posted third-quarter results that beat analysts’ estimates and raised its full-year outlook, …
Tag:
Novartis
-
-
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to …
-
-
Drugmakers are betting that delivering radiation directly to tumors will become the next big cancer …
-
Switch the Market flag for targeted data from your country of choice. Open the menu …
-
Key Takeaways Novartis posted second-quarter net sales and adjusted profit that beat analysts’ expectations. The …
-
Mutual FundsNews
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales Climb
by adminKey Takeaways Novartis beat first-quarter forecasts for profit and sales on rising demand for its …
-
Mutual FundsNews
Novartis to acquire German Biotech MorphoSys for $2.9B, Expanding Cancer Drug Pipeline
by adminKEY TAKEAWAYS Novartis plans to acquire MorphoSys for $2.9 billion to expand its cancer treatment …
-
Mutual FundsNews
Novartis Stock Slumps After Drugmaker’s Earnings, Guidance Fall Short of Expectations
by adminKey Takeaways Novartis missed forecasts for quarterly results and guidance, and ended a cancer drug …